CLASS II Drug recall · Reported 5 Oct 2022 · FDA Enforcement Report

Budesonide Inhalation Suspension 0.25mg/, For Inhalation Only recalled

Cipla is recalling Budesonide Inhalation Suspension 0.25mg/, For Inhalation Only, distributed nationwide in the US. The recall was initiated on 15 Sep 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #s: GA20080, GA20081, GA20094, Exp. 01/2024
NDC69097-318, 69097-319, 69097-321
Quantity recalled641,160 ampules

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1545-2022
FDA event ID
90864
Recalling firm
Cipla, Warren, NJ
Manufacturer
Cipla USA Inc.
Classification
Class II
Status
Terminated
Recall initiated
15 Sep 2022
FDA classified
27 Sep 2022
Reported
5 Oct 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

15 Sep 2022Recall initiated by company
27 Sep 2022Classified by FDA+12 days
5 Oct 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules per pouch, Sterile Suspension, Manufactured by: Cipla Ltd., India, Manufactured for Cipla USA Inc., Warren NJ, NDC# 69097-318-86.

Where it was distributed

Nationwide in the USA and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility

Which lots are affected?

Lot #s: GA20080, GA20081, GA20094, Exp. 01/2024

Where was it sold?

Nationwide in the USA and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Cipla

All 14
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIPhytonadione Injectable Emulsion, USP 10mg/mL recalled by CiplaPhytonadioneCiplaPotency & AssayNationwide
DrugCLASS IIArformoterol Tartrate Inhalation Solution, 15 mcg/ Sterile Unit-Dose recalledArformoterol TartrateCiplaSterilityNationwide
DrugCLASS IIDifluprednate Ophthalmic Emulsion recalled by CIPLADifluprednateCiplaSterilityNationwide
DrugCLASS IIDifluprednate Ophthalmic Emulsion recalled by CIPLACiplaSterilityNationwide
DrugCLASS IIDifluprednate Ophthalmic Emulsion recalled by CIPLADifluprednateCiplaSterilityNationwide

Other Budesonide recalls

All 10